Literature DB >> 14498753

Appropriate empirical antibacterial therapy for nosocomial infections: getting it right the first time.

Marin Kollef1.   

Abstract

The increasing presence of drug-resistant bacterial infections among hospitalised patients has resulted in greater numbers of patients receiving inappropriate antimicrobial treatment. This has led to the development of a novel paradigm guiding the administration of empirical antimicrobial therapy for patients with serious infections in the hospital setting. Antibacterial de-escalation is an approach to antibacterial utilisation that attempts to balance the need to provide appropriate, initial antibacterial treatment while limiting the emergence of antibacterial resistance. The goal of de-escalation is to prescribe an initial antibacterial regimen that will cover the most likely bacterial pathogens associated with infection while minimising the emergence of antibacterial resistance. Antibacterial resistance is minimised by narrowing the antibacterial regimen once the pathogens and their susceptibility profiles are determined, and by employing the shortest course of therapy clinically acceptable.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14498753     DOI: 10.2165/00003495-200363200-00001

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  62 in total

Review 1.  Hospital-acquired pneumonia and de-escalation of antimicrobial treatment.

Authors:  M H Kollef
Journal:  Crit Care Med       Date:  2001-07       Impact factor: 7.598

2.  Improving empirical antibiotic treatment: prospective, nonintervention testing of a decision support system.

Authors:  L Leibovici; V Gitelman; Y Yehezkelli; O Poznanski; G Milo; M Paul; P Ein-Dor
Journal:  J Intern Med       Date:  1997-11       Impact factor: 8.989

Review 3.  Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals.

Authors:  D M Shlaes; D N Gerding; J F John; W A Craig; D L Bornstein; R A Duncan; M R Eckman; W E Farrer; W H Greene; V Lorian; S Levy; J E McGowan; S M Paul; J Ruskin; F C Tenover; C Watanakunakorn
Journal:  Clin Infect Dis       Date:  1997-09       Impact factor: 9.079

4.  Outbreak of Enterobacter cloacae related to understaffing, overcrowding, and poor hygiene practices.

Authors:  S Harbarth; P Sudre; S Dharan; M Cadenas; D Pittet
Journal:  Infect Control Hosp Epidemiol       Date:  1999-09       Impact factor: 3.254

5.  Improving empiric antibiotic selection using computer decision support.

Authors:  R S Evans; D C Classen; S L Pestotnik; H P Lundsgaarde; J P Burke
Journal:  Arch Intern Med       Date:  1994-04-25

6.  The role of understaffing in central venous catheter-associated bloodstream infections.

Authors:  S K Fridkin; S M Pear; T H Williamson; J N Galgiani; W R Jarvis
Journal:  Infect Control Hosp Epidemiol       Date:  1996-03       Impact factor: 3.254

7.  A randomized, prospective evaluation of an interventional program to discontinue intravenous antibiotics at two tertiary care teaching institutions.

Authors:  T C Bailey; D J Ritchie; S T McMullin; M Kahn; R M Reichley; E Casabar; W Shannon; W C Dunagan
Journal:  Pharmacotherapy       Date:  1997 Mar-Apr       Impact factor: 4.705

8.  Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients.

Authors:  M H Kollef; G Sherman; S Ward; V J Fraser
Journal:  Chest       Date:  1999-02       Impact factor: 9.410

9.  Community-acquired methicillin-resistant Staphylococcus aureus infections in France: emergence of a single clone that produces Panton-Valentine leukocidin.

Authors:  Philippe Dufour; Yves Gillet; Michèle Bes; Gerard Lina; François Vandenesch; Daniel Floret; Jerome Etienne; Hervé Richet
Journal:  Clin Infect Dis       Date:  2002-09-03       Impact factor: 9.079

10.  Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia.

Authors:  Manuel Iregui; Suzanne Ward; Glenda Sherman; Victoria J Fraser; Marin H Kollef
Journal:  Chest       Date:  2002-07       Impact factor: 9.410

View more
  26 in total

1.  Usefulness of blood cultures in the management of febrile patients in long-term care facilities.

Authors:  D M Vandijck; J M Decruyenaere; S I Blot
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-04       Impact factor: 3.267

2.  [Prevention and control of the spread of vancomycin-resistant enterococci: results of a workshop held by the German Society for Hygiene and Microbiology].

Authors:  R-P Vonberg; I F Chaberny; A Kola; F Mattner; S Borgmann; M Dettenkofer; D Jonas; A-M Fahr; I Klare; G Werner; K Weist; C Wendt; P Gastmeier
Journal:  Anaesthesist       Date:  2007-02       Impact factor: 1.041

Review 3.  Value of lower respiratory tract surveillance cultures to predict bacterial pathogens in ventilator-associated pneumonia: systematic review and diagnostic test accuracy meta-analysis.

Authors:  Nele Brusselaers; Sonia Labeau; Dirk Vogelaers; Stijn Blot
Journal:  Intensive Care Med       Date:  2012-11-28       Impact factor: 17.440

Review 4.  The Cost-Effectiveness of Rapid Diagnostic Testing for the Diagnosis of Bloodstream Infections with or without Antimicrobial Stewardship.

Authors:  Elina Eleftheria Pliakos; Nikolaos Andreatos; Fadi Shehadeh; Panayiotis D Ziakas; Eleftherios Mylonakis
Journal:  Clin Microbiol Rev       Date:  2018-05-30       Impact factor: 26.132

Review 5.  Critical issues in the clinical management of complicated intra-abdominal infections.

Authors:  Stijn Blot; Jan J De Waele
Journal:  Drugs       Date:  2005       Impact factor: 9.546

6.  Risk factors for treatment failure in renal suppurative infections.

Authors:  Miroslav M Stojadinović; Sava R Mićić; Dragan R Milovanović; Slobodan M Janković
Journal:  Int Urol Nephrol       Date:  2008-08-15       Impact factor: 2.370

7.  The sequence-activity relationship between metallo-β-lactamases IMP-1, IMP-6, and IMP-25 suggests an evolutionary adaptation to meropenem exposure.

Authors:  Eleanor M Liu; Kevin M Pegg; Peter Oelschlaeger
Journal:  Antimicrob Agents Chemother       Date:  2012-09-24       Impact factor: 5.191

Review 8.  Meropenem: a review of its use in the treatment of serious bacterial infections.

Authors:  Claudine M Baldwin; Katherine A Lyseng-Williamson; Susan J Keam
Journal:  Drugs       Date:  2008       Impact factor: 9.546

9.  Less is more: combination antibiotic therapy for the treatment of gram-negative bacteremia in pediatric patients.

Authors:  Pranita D Tamma; Alison E Turnbull; Anthony D Harris; Aaron M Milstone; Alice J Hsu; Sara E Cosgrove
Journal:  JAMA Pediatr       Date:  2013-10       Impact factor: 16.193

10.  Cost-effectiveness of micafungin as an alternative to fluconazole empiric treatment of suspected ICU-acquired candidemia among patients with sepsis: a model simulation.

Authors:  Marya D Zilberberg; Smita Kothari; Andrew F Shorr
Journal:  Crit Care       Date:  2009-06-19       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.